Clinical Trials in Salt Lake City

Showing 3961-3980 of 16,694 trials

Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

NCT06094478

Most stroke patients are initially evaluated at the closest hospital but some need to be transferred to a hospital that can provide more advanced care. The "Door-In-Door-Out" (DIDO) process at the first hospital can take time making transferred patients no longer able to get the advanced treatments. This study will help hospitals across the US "stand up" new ways to evaluate stroke patients, decide who needs to be transferred, and transfer them quickly for advanced treatment.

Stroke, AcuteIschemic Stroke, AcuteHemorrhagic Stroke

University of Chicago900 participantsStarted Oct 2024

New Haven, Connecticut, United States • Miami, Florida, United States • Atlanta, Georgia, United States +4 more locations

RECRUITING< 1 mile

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

NCT05059444

The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early-stage solid tumors. It is necessary that ctDNA test results are linked to clinical outcomes in order to demonstrate clinical validity for recurrence detection and explore its value in a healthcare environment subject to cost containment.

Bladder CarcinomaUreter CarcinomaRenal Pelvis Carcinoma+13 more

Guardant Health, Inc.2,020 participantsStarted Sep 2021

Birmingham, Alabama, United States • Chandler, Arizona, United States • Hot Springs, Arkansas, United States +54 more locations

Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Find Trials by Condition in Salt Lake City

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

CCT-102 or Expectant Management in Delayed Pregnancy Loss

INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation

Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults

A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis

Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)

ERG Components in Schizophrenia and Bipolar Disorder Type I

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma

Families Left Behind

PTG-300 in Subjects With Hereditary Hemochromatosis

STICH3C Cardiac Magnetic Resonance Observational Study

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant